Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2012

Open Access 01-12-2012 | Research

The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study

Authors: Geping Yin, Juan Li, Tongyu Zhu, Xiaoli Zhao

Published in: World Journal of Surgical Oncology | Issue 1/2012

Login to get access

Abstract

Background

Currently the routine non-invasive screening methods for cervical intraepithelial neoplasia (CIN) and cervical cancer are Thinprep cytology test (TCT) and human papillomavirus testing. However, both methods are limited by the high false positive and false negative rates and lack of association with patients’ prognosis, especially for the early detection of pro-malignant CIN. The aim of the study was to investigate the role of genomic amplification of human telomerase gene (hTERC) in the diagnosis and prognosis of CIN.

Methods

The study group consisted of specimens of exfoliated cervical cells from 151 patients, including 27 with CIN I, 54 with CIN II/III, 17 with carcinoma in situ, and 28 with invasive squamous carcinoma, as well as 25 patients who were at 2-year follow-up after either Loop Electrosurgical Excision treatment (n = 11) or radical surgery (n = 14). hTERC amplification was detected by dual-color interphase fluorescence in situ hybridization (FISH), and the results were compared with TCT and histologic examination. The final diagnosis was determined by the pathological examination. The control group consisted of specimens of exfoliated cervical cells from 40 normal women.

Results

The percentage of cervical exfoliated cells with positive hTERC amplification and incidence rates of hTERC amplification were 9.2% ± 4.6% and 44.4% (12/27) respectively in patients with CIN I; 16.0% ± 14.4% and 85.1% (46/54) in patients with CIN II/III; 19.7% ± 13.3% and 88.3% (15 /17) in patients with carcinoma in situ; 47.0% ± 25.2% and 100% (28/28)in patients with invasive squamous carcinoma. There was statistically significant difference between the control and study group (P <0.01), and between the patients with various diseases within the study group (P <0.05).

Conclusion

The detection of genomic amplification of hTERC using FISH is a non-invasive and effective approach for CIN.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zhang D, Zhang Q, Zhou L, Huo L, Zhang Y, Shen Z, Zhu Y: Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and −58 in esophageal and cervical cancer: a case–control study. BMC Cancer. 2010, 10: 650-10.1186/1471-2407-10-650.PubMedCentralCrossRefPubMed Zhang D, Zhang Q, Zhou L, Huo L, Zhang Y, Shen Z, Zhu Y: Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and −58 in esophageal and cervical cancer: a case–control study. BMC Cancer. 2010, 10: 650-10.1186/1471-2407-10-650.PubMedCentralCrossRefPubMed
2.
go back to reference Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ: Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination. J Natl Cancer Inst. 2008, 100: 308-320. 10.1093/jnci/djn019.PubMedCentralCrossRefPubMed Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ: Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination. J Natl Cancer Inst. 2008, 100: 308-320. 10.1093/jnci/djn019.PubMedCentralCrossRefPubMed
3.
go back to reference Kim JJ, Ortendahl J, Goldie SJ: Cost-effectiveness of HPV vaccination and cervical cancer screening in women over Age 30 in the United States. Ann Intern Med. 2009, 151: 538-545.PubMedCentralCrossRefPubMed Kim JJ, Ortendahl J, Goldie SJ: Cost-effectiveness of HPV vaccination and cervical cancer screening in women over Age 30 in the United States. Ann Intern Med. 2009, 151: 538-545.PubMedCentralCrossRefPubMed
4.
go back to reference Insinga RP, Liaw KL, Johnson LG, Madeleine MM: A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal and vulvar pre-cancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1611-1622. 10.1158/1055-9965.EPI-07-2922.PubMedCentralCrossRefPubMed Insinga RP, Liaw KL, Johnson LG, Madeleine MM: A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal and vulvar pre-cancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1611-1622. 10.1158/1055-9965.EPI-07-2922.PubMedCentralCrossRefPubMed
5.
go back to reference Kailash U, Soundararajan CC, Lakshmy R, Arora R, Vivekanandhan S, Das BC: Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer. 2006, 95: 1250-1257. 10.1038/sj.bjc.6603375.PubMedCentralCrossRefPubMed Kailash U, Soundararajan CC, Lakshmy R, Arora R, Vivekanandhan S, Das BC: Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer. 2006, 95: 1250-1257. 10.1038/sj.bjc.6603375.PubMedCentralCrossRefPubMed
6.
go back to reference Andersson S, Sowjanya P, Wangsa D, Hjerpe A, Johansson B, Auer G, Gravitt PE, Larsson C, Wallin KL, Ried T, Heselmeyer-Haddad K: Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal pap smears. Am J Pathol. 2009, 175: 1831-1847. 10.2353/ajpath.2009.090122.PubMedCentralCrossRefPubMed Andersson S, Sowjanya P, Wangsa D, Hjerpe A, Johansson B, Auer G, Gravitt PE, Larsson C, Wallin KL, Ried T, Heselmeyer-Haddad K: Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal pap smears. Am J Pathol. 2009, 175: 1831-1847. 10.2353/ajpath.2009.090122.PubMedCentralCrossRefPubMed
7.
go back to reference Sokolova I, Algeciras-Schimnich A, Song M, Sitailo S, Policht F, Kipp BR, Voss JS, Halling KC, Ruth A, King W, Underwood D, Brainard J, Morrison L: Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens. J Mol Diagn. 2007, 9: 604-611. 10.2353/jmoldx.2007.070007.PubMedCentralCrossRefPubMed Sokolova I, Algeciras-Schimnich A, Song M, Sitailo S, Policht F, Kipp BR, Voss JS, Halling KC, Ruth A, King W, Underwood D, Brainard J, Morrison L: Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens. J Mol Diagn. 2007, 9: 604-611. 10.2353/jmoldx.2007.070007.PubMedCentralCrossRefPubMed
8.
go back to reference Heselmeyer-Haddad K, Sommerfeld K, White NM, Chaudhri N, Morrison LE, Palanisamy N, Wang ZY, Auer G, Steinberg W, Ried T: Genomic amplification of the human telomerase gene (TERC) in pap smears predics the development of cervical cancer. Am J Pathol. 2005, 166: 1229-1238. 10.1016/S0002-9440(10)62341-3.PubMedCentralCrossRefPubMed Heselmeyer-Haddad K, Sommerfeld K, White NM, Chaudhri N, Morrison LE, Palanisamy N, Wang ZY, Auer G, Steinberg W, Ried T: Genomic amplification of the human telomerase gene (TERC) in pap smears predics the development of cervical cancer. Am J Pathol. 2005, 166: 1229-1238. 10.1016/S0002-9440(10)62341-3.PubMedCentralCrossRefPubMed
9.
go back to reference Ryu A, Nam K, Chung S, Kim J, Lee H, Koh E, Bae D: Absence of dysplasia in the excised cervix by a loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia. J Gynecol Oncol. 2010, 21: 87-92. 10.3802/jgo.2010.21.2.87.PubMedCentralCrossRefPubMed Ryu A, Nam K, Chung S, Kim J, Lee H, Koh E, Bae D: Absence of dysplasia in the excised cervix by a loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia. J Gynecol Oncol. 2010, 21: 87-92. 10.3802/jgo.2010.21.2.87.PubMedCentralCrossRefPubMed
10.
go back to reference Melnikow J, McGahan C, Sawaya GF, Ehlen T, Coldman A: Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia cohort study. J Natl Cancer Inst. 2009, 101: 721-728. 10.1093/jnci/djp089.PubMedCentralCrossRefPubMed Melnikow J, McGahan C, Sawaya GF, Ehlen T, Coldman A: Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia cohort study. J Natl Cancer Inst. 2009, 101: 721-728. 10.1093/jnci/djp089.PubMedCentralCrossRefPubMed
11.
go back to reference Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD: Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst. 2010, 102: 315-324. 10.1093/jnci/djq001.PubMedCentralCrossRefPubMed Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD: Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst. 2010, 102: 315-324. 10.1093/jnci/djq001.PubMedCentralCrossRefPubMed
12.
go back to reference Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE: Impact of improved classification on the association of human papillomavirus with cervical precancer. Am J Epidemiol. 2010, 171: 155-163. 10.1093/aje/kwp390.PubMedCentralCrossRefPubMed Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE: Impact of improved classification on the association of human papillomavirus with cervical precancer. Am J Epidemiol. 2010, 171: 155-163. 10.1093/aje/kwp390.PubMedCentralCrossRefPubMed
13.
go back to reference Moscicki AB, Ma Y, Wibbelsman C, Darragh TM, Powers A, Farhat S, Shiboski S: Rate of and risks for regression of CIN-2 in adolescents and young women. Obstet Gynecol. 2010, 116: 1373-1380. 10.1097/AOG.0b013e3181fe777f.PubMedCentralCrossRefPubMed Moscicki AB, Ma Y, Wibbelsman C, Darragh TM, Powers A, Farhat S, Shiboski S: Rate of and risks for regression of CIN-2 in adolescents and young women. Obstet Gynecol. 2010, 116: 1373-1380. 10.1097/AOG.0b013e3181fe777f.PubMedCentralCrossRefPubMed
14.
go back to reference Chalermchockcharoenkit A, Chayachinda C, Thamkhantho M, Komoltri C: Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study. BMC Infect Dis. 2011, 11: 8-10.1186/1471-2334-11-8.PubMedCentralCrossRefPubMed Chalermchockcharoenkit A, Chayachinda C, Thamkhantho M, Komoltri C: Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study. BMC Infect Dis. 2011, 11: 8-10.1186/1471-2334-11-8.PubMedCentralCrossRefPubMed
15.
go back to reference Galgano MT, Castle PE, Atkins KA, Brix WK, Nassau SR, Stoler MH: Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol. 2010, 34: 1077-1087. 10.1097/PAS.0b013e3181e8b2c4.PubMedCentralCrossRefPubMed Galgano MT, Castle PE, Atkins KA, Brix WK, Nassau SR, Stoler MH: Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol. 2010, 34: 1077-1087. 10.1097/PAS.0b013e3181e8b2c4.PubMedCentralCrossRefPubMed
16.
go back to reference Moscicki AB, Ma Y, Wibbelsman C, Powers A, Darragh TM, Farhat S, Shaber R, Shiboski S: Risks for cervical intraepithelial neoplasia-3 among adolescent and young women with abnormal cytology. Obstet Gynecol. 2008, 112: 1335-1342. 10.1097/AOG.0b013e31818c9222.PubMedCentralCrossRefPubMed Moscicki AB, Ma Y, Wibbelsman C, Powers A, Darragh TM, Farhat S, Shaber R, Shiboski S: Risks for cervical intraepithelial neoplasia-3 among adolescent and young women with abnormal cytology. Obstet Gynecol. 2008, 112: 1335-1342. 10.1097/AOG.0b013e31818c9222.PubMedCentralCrossRefPubMed
17.
go back to reference Li Y, Zeng WJ, Ye F, Wang XY, Lü WG, Ma D, Wei LH, Xie X: Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive. Gynecol Oncol. 2011, 120: 73-78. 10.1016/j.ygyno.2010.10.007.CrossRefPubMed Li Y, Zeng WJ, Ye F, Wang XY, Lü WG, Ma D, Wei LH, Xie X: Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive. Gynecol Oncol. 2011, 120: 73-78. 10.1016/j.ygyno.2010.10.007.CrossRefPubMed
18.
go back to reference Li Y, Ye F, Lü WG, Zeng WJ, Wei LH, Xie X: Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings. Int J Gynecol Cancer. 2010, 20: 631-637. 10.1111/IGC.0b013e3181c50c7e.CrossRefPubMed Li Y, Ye F, Lü WG, Zeng WJ, Wei LH, Xie X: Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings. Int J Gynecol Cancer. 2010, 20: 631-637. 10.1111/IGC.0b013e3181c50c7e.CrossRefPubMed
19.
go back to reference Hopman AH, Theelen W, Hommelberg PP, Kamps MA, Herrington CS, Morrison LE, Speel EJ, Smedts F, Ramaekers FC: Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol. 2006, 210: 412-419. 10.1002/path.2070.CrossRefPubMed Hopman AH, Theelen W, Hommelberg PP, Kamps MA, Herrington CS, Morrison LE, Speel EJ, Smedts F, Ramaekers FC: Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol. 2006, 210: 412-419. 10.1002/path.2070.CrossRefPubMed
20.
go back to reference Heselmeyer-Haddad K, Janz V, Castle PE, Chaudhri N, White N, Wilber K, Morrison LE, Auer G, Burroughs FH, Sherman ME, Ried T: Detection of genomic amplification of the human telomerase gene (TERC) in cytogic specimen as a genetic test for the diagnosis of cervical dysplasia. Am J Pathol. 2003, 163: 1405-1416. 10.1016/S0002-9440(10)63498-0.PubMedCentralCrossRefPubMed Heselmeyer-Haddad K, Janz V, Castle PE, Chaudhri N, White N, Wilber K, Morrison LE, Auer G, Burroughs FH, Sherman ME, Ried T: Detection of genomic amplification of the human telomerase gene (TERC) in cytogic specimen as a genetic test for the diagnosis of cervical dysplasia. Am J Pathol. 2003, 163: 1405-1416. 10.1016/S0002-9440(10)63498-0.PubMedCentralCrossRefPubMed
21.
go back to reference Jin Y, Li JP, He D, Tang LY, Zee CS, Guo SZ, Zhou J, Chen JN, Shao CK: Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization. Asian Pac J Cancer Prev. 2011, 12: 1167-1171.PubMed Jin Y, Li JP, He D, Tang LY, Zee CS, Guo SZ, Zhou J, Chen JN, Shao CK: Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization. Asian Pac J Cancer Prev. 2011, 12: 1167-1171.PubMed
22.
go back to reference Xiang L, Yang H, Li J, Wu X, Zhou X: Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III. Diagn Cytopathol. 2011, 10.1002/dc.21635. Xiang L, Yang H, Li J, Wu X, Zhou X: Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III. Diagn Cytopathol. 2011, 10.1002/dc.21635.
Metadata
Title
The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study
Authors
Geping Yin
Juan Li
Tongyu Zhu
Xiaoli Zhao
Publication date
01-12-2012
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2012
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-10-168

Other articles of this Issue 1/2012

World Journal of Surgical Oncology 1/2012 Go to the issue